UIM9:XETRA:XETRA-UBS ETF SICAV - MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 42.835

Change

+0.01 (+0.02)%

Market Cap

USD 2.02B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.67 (+1.29%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.21 (+1.23%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.32 (+1.17%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.36 (+1.27%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.36%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.12 (+0.26%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+0.86 (+0.59%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.62 (+1.21%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.14 (+1.11%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+5.66 (+0.96%)

USD 80.38B

ETFs Containing UIM9:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.83% 67% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.83% 67% D+ 69% C-
Trailing 12 Months  
Capital Gain 25.51% 71% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.51% 71% C- 72% C
Trailing 5 Years  
Capital Gain 44.69% 69% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.69% 69% C- 72% C
Average Annual (5 Year Horizon)  
Capital Gain 10.57% 70% C- 69% C-
Dividend Return 11.50% 73% C 70% C-
Total Return 0.93% 62% D 43% F
Risk Return Profile  
Volatility (Standard Deviation) 15.93% 31% F 43% F
Risk Adjusted Return 72.19% 68% D+ 72% C
Market Capitalization 2.02B 87% B+ 77% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.